Related references
Note: Only part of the references are listed.Selection of Clinically Meaningful Primary Endpoints in Phase 3 Clinical Trials in Idiopathic Pulmonary Fibrosis
Williamson Z. Bradford et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2013)
Progression-free survival and overall survival in phase III trials of molecular-targeted agents in advanced non-small-cell lung cancer
Katsuyuki Hotta et al.
LUNG CANCER (2013)
Idiopathic Pulmonary Fibrosis: Clinically Meaningful Primary Endpoints in Phase 3 Clinical Trials
Ganesh Raghu et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2012)
A Multidimensional Index and Staging System for Idiopathic Pulmonary Fibrosis
Brett Ley et al.
ANNALS OF INTERNAL MEDICINE (2012)
A 3-year longitudinal study of sleep disordered breathing in the elderly
Emilia Sforza et al.
EUROPEAN RESPIRATORY JOURNAL (2012)
Hot off the breath: Mortality as a primary end-point in IPF treatment trials: the best is the enemy of the good
Athol U. Wells et al.
THORAX (2012)
Forced Vital Capacity in Patients with Idiopathic Pulmonary Fibrosis Test Properties and Minimal Clinically Important Difference
Roland M. du Bois et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2011)
Ascertainment of Individual Risk of Mortality for Patients with Idiopathic Pulmonary Fibrosis
Roland M. du Bois et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2011)
Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY): two randomised trials
Paul W. Noble et al.
LANCET (2011)
Efficacy and safety of statin treatment for cardiovascular disease: a network meta-analysis of 170 255 patients from 76 randomized trials
E. J. Mills et al.
QJM-AN INTERNATIONAL JOURNAL OF MEDICINE (2011)
Six-Minute-Walk Test in Idiopathic Pulmonary Fibrosis
Roland M. du Bois et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2010)
Marginal decline in forced vital capacity is associated with a poor outcome in idiopathic pulmonary fibrosis
C. J. Zappala et al.
EUROPEAN RESPIRATORY JOURNAL (2010)
The 6 minute walk in idiopathic pulmonary fibrosis: longitudinal changes and minimum important difference
Jeffrey J. Swigris et al.
THORAX (2010)
Effect of interferon gamma-1b on survival in patients with idiopathic pulmonary fibrosis (INSPIRE): a multicentre, randomised, placebo-controlled trial
Talmadge E. King et al.
LANCET (2009)
Small changes in six-minute walk distance are important in diffuse parenchymal lung disease
Anne E. Holland et al.
RESPIRATORY MEDICINE (2009)
Primary Prevention of Cardiovascular Mortality and Events With Statin Treatments
Edward J. Mills et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2008)
Physiology is a stronger predictor of survival than pathology in fibrotic interstitial pneumonia
Y Jegal et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2005)
Meta-analysis of large randomized controlled trials to evaluate the impact of statins on cardiovascular outcomes
BMY Cheung et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2004)
Effectiveness of statin therapy in adults with coronary heart disease
TJ Wilt et al.
ARCHIVES OF INTERNAL MEDICINE (2004)
Fibrotic idiopathic interstitial pneumonia - The prognostic value of longitudinal functional trends
PI Latsi et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2003)
Prognostic implications of physiologic and radiographic changes in idiopathic interstitial pneumonia
KR Flaherty et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2003)
Changes in clinical and physiologic variables predict survival in idiopathic pulmonary fibrosis
HR Collard et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2003)
Share Paper
